|
Usefulness and Complications of Ultrasonography-
Guided Vacuum Assisted Biopsy for the Removal of
Benign Breast Lesions |
|
Keum Won Kim, MD1 Young Jun Cho, MD1, Cheol Mog Hwang, MD1, Dae Ho Kim, MD1, Kyoung-Jin Oh, MD1, Kyu Soon Kim, MD2, Dae Sung Yoon, MD3 |
|
1Department of Radiology, College of Medicine, Konyang University
2Department of Radiology, College of Medicine, Eulji University
3Department of General Surgery, College of Medicine, Konyang University |
|
Purpose: To evaluate the usefulness and complications of ultrasonography (US)-
guided vacuum assisted biopsy (VAB) for the removal of benign breast lesions, and
the short- and long-term changes after VAB as shown on follow-up US.
Materials and Methods: From January 2007 to May 2008, 110 sonographically
benign lesions in 62 patients were sampled via US-guided VAB. We prospectively
evaluated the sonographic findings 1 week and 6 months after VAB in all patients to
determine the presence of residual tumors, hematomas and scarring. We evaluated
the prevalence of hematoma, pain, skin dimpling, fibrotic scarring and residual tumors
after US-guided VAB, and determined if correlation existed between complications,
size of the lesions and lesion pathology.
Results: The age of the patients was 15-65 years, with a mean age of 36.5 years.
The pathologic diagnoses were fibroadenomas (41.8%, n = 46), fibrocystic changes
(30.9%, n = 34), fibroadenomatoid hyperplasias (13.6%, n = 15), fibroadenomatoid
mastopathies (6.3%, n = 7), adenoses (3.6%, n = 4), hamartomas (1.8%, n = 2) and
phyllodes tumors (1.8%, n = 2). Complications 1 week after the US-guided VAB
included hematomas (n = 39, 35.4%), pain (n = 23, 20.9%), fibrotic scars (n = 26,
23.68%), residual tumors (n = 4, 3.6%) and skin dimplings (n = 4, 3.6%).
Complications 6 months after the US-guided VAB included hematomas (n = 12,
10.9%), pain (n = 3 2.7%), fibrotic scars (n = 14, 12.7%), and residual tumors (n = 17,
15.4%). Residual tumor after US-guided VAB existed in association with 15.2% of
fibroadenomas (7/46), 14.7% of fibrocystic changes (5/34), 13.3% of fibroadenomatoid
hyperplasias (2/15), 25% of adenoses (1/4), and 100% of phyllodes tumors (2/2).
Conclusion: US-guided VAB is an effective procedure for removal of benign breast
lesion. Periodic follow up studies at 1week and 6months after the VAB are useful to
assess Post-VAB complications. |
|
Keyword : Breast USG; Benign breast lesion; Breast biopsy |
|
pdf파일 : 199-207김금원.pdf
|
|